UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

60 Degrees Pharmaceuticals Inc (SXTP)

60 Degrees Pharmaceuticals Inc (SXTP)
1.8800 -0.0100 (-0.53%) 03/26/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 1.9900 +0.1000 (+5.29%) 09:28 ET
Quote Overview for Wed, Mar 26th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.8000
Day High
1.9771
Open 1.9000
Previous Close 1.8900 1.8900
Volume 40,200 40,200
Avg Vol 38,435 38,435
Stochastic %K 64.81% 64.81%
Weighted Alpha -85.51 -85.51
5-Day Change -0.1100 (-5.53%) -0.1100 (-5.53%)
52-Week Range 1.4100 - 35.9940 1.4100 - 35.9940
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,784
  • Shares Outstanding, K 1,473
  • Annual Sales, $ 250 K
  • Annual Income, $ -3,770 K
  • EBIT $ -10 M
  • EBITDA $ -8 M
  • 60-Month Beta 4.52
  • Price/Sales 0.90
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -4.77
  • Number of Estimates 1
  • High Estimate -4.77
  • Low Estimate -4.77
  • Prior Year -26.41
  • Growth Rate Est. (year over year) +81.94%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4100 +33.33%
on 03/10/25
Period Open: 2.0100
2.1300 -11.74%
on 03/18/25
-0.1300 (-6.47%)
since 02/26/25
3-Month
1.4100 +33.33%
on 03/10/25
Period Open: 6.7000
8.0000 -76.50%
on 01/08/25
-4.8200 (-71.94%)
since 12/26/24
52-Week
1.4100 +33.33%
on 03/10/25
Period Open: 15.1920
35.9940 -94.78%
on 07/19/24
-13.3120 (-87.63%)
since 03/26/24

Most Recent Stories

More News
60 Degrees Pharmaceuticals and Fathom Holdings Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESS Newswire / February 21, 2025 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc. (Nasdaq:SXTP) and Fathom Holdings Inc. (Nasdaq:FTHM) on the RedChip Small...

FTHM : 1.0000 (+1.73%)
SXTP : 1.8800 (-0.53%)
60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split

SXTP : 1.8800 (-0.53%)
SXTPW : 0.0240 (-10.11%)
Sixty Degrees Pharmaceuticals to Ensure Continuity of Tafenoquine Supply in U.S. by Importing Limited Quantity of KODATEF®

SXTP : 1.8800 (-0.53%)
SXTPW : 0.0240 (-10.11%)
60 Degrees Pharma Announces Closing of $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SXTP : 1.8800 (-0.53%)
SXTPW : 0.0240 (-10.11%)
60 Degrees Pharma Announces $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SXTP : 1.8800 (-0.53%)
SXTPW : 0.0240 (-10.11%)
RedChip Launches RedChat: Revolutionary AI Chatbot for Small-Cap Stock Analysis

RedChat provides data-driven precision, real-time efficiency, and comprehensive coverage

BFRG : 1.90 (-8.65%)
SXTP : 1.8800 (-0.53%)
GRRR : 25.76 (-3.77%)
CNTM : 0.6187 (+0.70%)
OSTX : 1.6300 (+2.52%)
RedChip Launches RedChat: Revolutionary AI Chatbot for Small-Cap Stock Analysis

RedChat provides data-driven precision, real-time efficiency, and comprehensive coverage

BFRG : 1.90 (-8.65%)
SXTP : 1.8800 (-0.53%)
GRRR : 25.76 (-3.77%)
CNTM : 0.6187 (+0.70%)
OSTX : 1.6300 (+2.52%)
60 Degrees Pharma Announces Closing of $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SXTP : 1.8800 (-0.53%)
SXTPW : 0.0240 (-10.11%)
60 Degrees Pharma Announces $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SXTP : 1.8800 (-0.53%)
SXTPW : 0.0240 (-10.11%)
60 Degrees Pharma Announces IRB Approval of Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis

SXTP : 1.8800 (-0.53%)
SXTPW : 0.0240 (-10.11%)

Business Summary

60 Degrees Pharmaceuticals Inc. specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. 60 Degrees Pharmaceuticals Inc. is based in WASHINGTON.

See More

Key Turning Points

3rd Resistance Point 2.1485
2nd Resistance Point 2.0628
1st Resistance Point 1.9714
Last Price 1.8800
1st Support Level 1.7943
2nd Support Level 1.7086
3rd Support Level 1.6172

See More

52-Week High 35.9940
Fibonacci 61.8% 22.7829
Fibonacci 50% 18.7020
Fibonacci 38.2% 14.6211
Last Price 1.8800
52-Week Low 1.4100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies